BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bartolini I, Nannini G, Risaliti M, Matarazzo F, Moraldi L, Ringressi MN, Taddei A, Amedei A. Impact of microbiota-immunity axis in pancreatic cancer management. World J Gastroenterol 2022; 28(32): 4527-4539 [PMID: PMC9476869 DOI: 10.3748/wjg.v28.i32.4527]
URL: https://www.wjgnet.com/1007-9327/full/v28/i32/4527.htm
Number Citing Articles
1
Emad Hamdy Gad. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies2023;  doi: 10.5772/intechopen.111726
2
Sara Fanijavadi, Lars Henrik Jensen. Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical OutcomesInternational Journal of Molecular Sciences 2025; 26(2): 730 doi: 10.3390/ijms26020730
3
Xuejiao Wei, Fei Wang, Peng Tan, Huiming Huang, Zhuguo Wang, Jinxin Xie, Longyan Wang, Dongxiao Liu, Zhongdong Hu. The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectivesPharmacological Research 2024; 203: 107148 doi: 10.1016/j.phrs.2024.107148
4
Xin Li, Zhihai Liang. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization studyJournal of Cellular and Molecular Medicine 2024; 28(8) doi: 10.1111/jcmm.18255